Ferric Carboxymaltose Injection

Form: Injection

Strength: 50 mg/mL

Reference Brands:

Category: Anemia

Ferric Carboxymaltose Injection (brand names Injectafer® in the U.S. and Ferinject® in the EU) is a high-concentration intravenous iron therapy used to treat iron deficiency anemia, particularly in patients who cannot tolerate oral iron or need rapid iron repletion. With a strength of 50 mg/mL, it allows for large, single-dose infusions, enhancing patient convenience and adherence. In the U.S. and EU, Ferric Carboxymaltose is in high demand across hospitals, dialysis centers, and specialty clinics. In the pharmaceutical B2B sector, it is supplied by licensed manufacturers, contract partners, and distributors to meet institutional needs and ensure global availability.